CUSIP: 055477103
What is CUSIP 055477103?
CUSIP 055477103 identifies BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 055477103:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 12% | $123,100,386 | 7,279,739 | RA Capital Management, L.P. | 26 Feb 2026 | |||
| Invus Global Management, LLC | 9.6% | $50,656,769 | 5,216,969 | Raymond Debbane | 30 Jun 2025 | |||
| Vestal Point Capital, LP | 6.5% | -30% | $62,669,750 | -$24,980,250 | 3,575,000 | -28% | Vestal Point Capital, LP | 31 Dec 2025 |
| FMR LLC | 6.1% | +20% | $56,333,763 | +$9,946,631 | 3,347,223 | +21% | FMR LLC | 31 Dec 2025 |
| T. Rowe Price Investment Management, Inc. | 5.9% | $56,737,510 | 3,236,595 | T. Rowe Price Investment Management, Inc. | 31 Dec 2025 | |||
| Deep Track Capital, LP | 5% | $48,207,500 | 2,750,000 | Deep Track Capital, LP | 05 Feb 2026 |
As of 31 Dec 2025, 140 institutional investors reported holding 57,096,017 shares of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX). This represents 90% of the company’s total 63,302,078 outstanding shares.
The largest institutional shareholders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11% | 6,955,993 | 0% | 1.2% | $117,069,362 |
| Siren, L.L.C. | 8.2% | 5,216,969 | 0% | 2.6% | $87,801,588 |
| Vestal Point Capital, LP | 5.6% | 3,575,000 | -30% | 2.2% | $60,167,250 |
| FMR LLC | 5.3% | 3,347,223 | +24% | 0% | $56,333,763 |
| T. Rowe Price Investment Management, Inc. | 5.1% | 3,236,595 | +596% | 0.03% | $54,472,000 |
| RED TREE MANAGEMENT, LLC | 5% | 3,170,509 | 0% | 49% | $53,359,666 |
| TPG GP A, LLC | 4.8% | 3,010,425 | 0% | 1.9% | $50,665,453 |
| JANUS HENDERSON GROUP PLC | 4.2% | 2,646,285 | 0.02% | $44,484,051 | |
| Deep Track Capital, LP | 4.1% | 2,614,004 | +7.7% | 1% | $43,993,687 |
| BlackRock, Inc. | 4% | 2,528,451 | +9.4% | 0% | $42,553,826 |
| Omega Fund Management, LLC | 3.5% | 2,204,650 | 0% | 13% | $37,104,260 |
| VANGUARD GROUP INC | 3.5% | 2,186,150 | -0.67% | 0% | $36,792,904 |
| STATE STREET CORP | 2.6% | 1,649,537 | +179% | 0% | $27,761,708 |
| FRANKLIN RESOURCES INC | 2.6% | 1,620,025 | 0.01% | $27,265,020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.5% | 1,559,535 | -11% | 0% | $26,248,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 811,400 | -2.4% | 0% | $13,658,764 |
| CITADEL ADVISORS LLC | 1.2% | 772,258 | 0.01% | $12,997,102 | |
| FIL Ltd | 1.2% | 758,493 | -5.6% | 0.01% | $12,765,437 |
| ACORN CAPITAL ADVISORS, LLC | 1% | 643,382 | 0% | 3.7% | $10,828,113 |
| Aisling Capital Management LP | 0.9% | 568,919 | 0% | 2% | $9,574,907 |
| GOLDMAN SACHS GROUP INC | 0.87% | 552,331 | +137% | 0% | $9,295,731 |
| MILLENNIUM MANAGEMENT LLC | 0.69% | 434,699 | -57% | 0.01% | $7,315,984 |
| Rock Springs Capital Management LP | 0.68% | 429,095 | +16% | 0.37% | $7,221,669 |
| Ensign Peak Advisors, Inc | 0.63% | 401,444 | 0.01% | $6,756,303 | |
| NAN FUNG TRINITY (HK) LTD | 0.59% | 372,385 | -3.2% | 0.5% | $6,267,240 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 57,096,017 | $960,809,333 | +$119,906,754 | $16.83 | 140 |
| 2025 Q3 | 49,994,786 | $789,088,187 | +$2,780,392 | $15.79 | 112 |
| 2025 Q2 | 51,165,684 | $475,330,436 | -$6,689,372 | $9.29 | 105 |
| 2025 Q1 | 48,567,553 | $633,357,650 | +$9,523,679 | $13.03 | 92 |
| 2024 Q4 | 46,709,070 | $813,618,424 | +$73,899,338 | $17.42 | 84 |
| 2024 Q3 | 36,408,664 | $927,393,381 | +$849,110,088 | $25.47 | 69 |